Physician profile
Beverly Ann Reader
NPI 1396937868
$637.87
in general payments reported to CMS, 2019-2025
10 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.96 · 2022: $118 · 2023: $203 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $127.29 | 2023 | Ingrezza |
| Alkermes, INC. | $118.39 | 2022 | |
| Bausch Health US, LLC | $90.28 | 2023-2025 | Aplenzin |
| Almatica Pharma LLC | $74.62 | 2025 | Loreev Xr |
| Abbvie INC. | $59.24 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $51.56 | 2025 | Rexulti |
| Lundbeck LLC | $42.87 | 2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $28.32 | 2020 | |
| Axsome Therapeutics, INC. | $22.66 | 2025 | Auvelity |
| Sunovion Pharmaceuticals INC. | $22.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Reader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.